Who owns ACASTI PHARMA INC?
- Ticker: GRCE
- CUSIP Number: 00439u104
Tip: Access positions for across all investors
Analyze quarterly positions in Acasti Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acasti Pharma stock
Who bought or sold ACASTI PHARMA INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| ADAR1 Capital Management | 774k | $2.9M | -19% | Dec 2024 |
|
| AIGH Capital Management | 521k | $2.0M | 100% | Dec 2024 |
|
| Bank of America Corporation | 495k | $1.9M | 100% | Dec 2024 |
|
| Vanguard Group | 225k | $857k | 100% | Dec 2024 |
|
| Renaissance Technologies | 43k | $161k | 100% | Dec 2024 |
|
| Citadel Advisors | 24k | $90k | 100% | Dec 2024 |
|
| National Bank Of Canada /fi/ | 2.7k | $10k | 100% | Dec 2024 |
|
| Morgan Stanley | 1.9k | $7.0k | 100% | Dec 2024 |
|
| Tower Research Capital | 1.5k | $5.6k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 546.00 | $0 | 100% | Dec 2024 |
|
| Activest Wealth Management | 104.00 | $389.001600 | 100% | Dec 2024 |
|
| Golden State Wealth Management | 31.00 | $115.998900 | 100% | Dec 2024 |
|
| Federation des caisses Desjardins du Quebec | 28.00 | $105.000000 | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 17.00 | $64.999500 | 100% | Dec 2024 |
|
| SBI Securities | 1.00 | $4.000000 | 100% | Dec 2024 |
|